These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24980576)

  • 1. Visceral leishmaniasis infection during adalimumab therapy: a case report and literature review.
    Tung Chen Y; Perales C; Lacruz J; Senent L; Salavert M
    Int J Rheum Dis; 2014 Sep; 17(7):822-4. PubMed ID: 24980576
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis.
    Berry CE; Tsai J; Tierney A; Pickles R
    Med J Aust; 2013 Apr; 198(6):331-3. PubMed ID: 23545033
    [No Abstract]   [Full Text] [Related]  

  • 3. A patient with rheumatoid arthritis, cryoglobulinaemia, and an "accidental" finding.
    Liapis K; Chung Y; Akhtar W; Taussig D
    BMJ; 2014 Apr; 348():g2701. PubMed ID: 24733745
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature.
    Català A; Roé E; Dalmau J; Pomar V; Muñoz C; Yelamos O; Puig L
    Dermatology; 2015; 230(3):204-7. PubMed ID: 25633623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
    Venizelos I; Tatsiou Z; Papathomas TG; Orazi A
    Int J Infect Dis; 2009 Jul; 13(4):e169-72. PubMed ID: 19026580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral Leishmaniasis as a complication of tumor necrosis factor inhibitor therapy.
    Clin Infect Dis; 2014 Dec; 59(12):iv. PubMed ID: 25574550
    [No Abstract]   [Full Text] [Related]  

  • 7. Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab.
    Moltó A; Mateo L; Lloveras N; Olivé A; Minguez S
    Joint Bone Spine; 2010 May; 77(3):271-3. PubMed ID: 20378385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate.
    Reina D; Cerdà D; Güell E; Martínez Montauti J; Pineda A; Corominas H
    Reumatol Clin; 2017; 13(6):354-356. PubMed ID: 27523470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multifocal cutaneous leishmaniasis due to Leishmania infantum under adalimumab therapy].
    Schneider P; Bouaziz JD; Foulet F; Duong TA; Allanore LV; Bagot M
    Ann Dermatol Venereol; 2009 Nov; 136(11):815-6. PubMed ID: 19917436
    [No Abstract]   [Full Text] [Related]  

  • 10. Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia.
    Pitini V; Cascio A; Arrigo C; Altavilla G
    Br J Haematol; 2012 Jan; 156(1):1. PubMed ID: 21790529
    [No Abstract]   [Full Text] [Related]  

  • 11. Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences.
    Juzlova K; Votrubova J; Kacerovska D; Lukas M; Bortlik M; Rohacova H; Nohynkova E; Vojackova N; Fialova J; Hercogova J
    Dermatol Ther; 2014; 27(3):131-4. PubMed ID: 24903470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral Leishmaniasis among immunosuppressed patients with rheumatic diseases.
    Erre GL; Mesina P; Tonelli N; Passiu G
    Clin Exp Rheumatol; 2010; 28(4):590-1. PubMed ID: 20659417
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB; Yang CM; Zhang CJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.
    Vigna E; De Vivo A; Gentile M; Morelli R; Lucia E; Mazzone C; Recchia AG; Vianelli N; Morabito F
    Transpl Infect Dis; 2010 Oct; 12(5):428-31. PubMed ID: 20534035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab.
    Kritikos K; Haritatos E; Tsigkos S; Gounari P; Skrapari I; Gounaris T; Sioula E
    J Clin Rheumatol; 2010 Jan; 16(1):38-9. PubMed ID: 20051756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case.
    Postorino MC; Bellantoni M; Catalano C; Caridi G; De Rosa M; Seck S; Enia G
    J Nephrol; 2011; 24(4):530-4. PubMed ID: 21607915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B.
    Tavil B; Seçmeer G; Ozen H; Cengiz AB; Unal S; Gürgey A
    Turk J Pediatr; 2008; 50(1):67-9. PubMed ID: 18365595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-emergence of visceral leishmaniasis in Gujarat, India.
    Sharma U; Redhu NS; Mathur P; Singh S
    J Vector Borne Dis; 2007 Sep; 44(3):230-2. PubMed ID: 17896628
    [No Abstract]   [Full Text] [Related]  

  • 19. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab.
    Bassetti M; Pizzorni C; Gradoni L; Del Bono V; Cutolo M; Viscoli C
    Rheumatology (Oxford); 2006 Nov; 45(11):1446-8. PubMed ID: 16887847
    [No Abstract]   [Full Text] [Related]  

  • 20. CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.
    Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Acta Derm Venereol; 2016 May; 96(4):570-1. PubMed ID: 26631390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.